Skip to content

    Recently Viewed

      Listening...

      A man and a boy getting haircuts at a barber shop

      “As black men, we keep things close to the hip": 5 questions for a urologist about prostate cancer

      The goal to eliminate prostate cancer starts with getting people to talk about it—especially Black men, who are two times more likely to die from the disease than most other men. For Black History Month, we spoke with a physician about building awareness and normalizing tough conversations.

      Share Article
      share to
      Most men don’t regularly talk about their prostate—the walnut-size gland just below the bladder that produces seminal fluid.

      But considering the statistics surrounding prostate cancer, they should. It’s the second most common cancer in males in the United States and one of the leading causes of cancer death among all men.

      And like many other types of cancer, it has a significant impact on Black communities. The numbers shine a harsh light on racial disparities: Prostate cancer makes up roughly 37% of all newly diagnosed cancer cases in Black men. Black men get prostate cancer at a younger age than men from other groups, and they are more likely to have advanced disease when they are diagnosed.

      Ultimately, Black men are twice as likely to die from prostate cancer than most other men.

      A headshot of Vincent M. Bivins, M.D., FACS, president of Urology Centers of Alabama
      However, when prostate cancer is detected earlier—either at a localized stage before the cancer has spread outside the prostate or a regional stage when spread is limited to nearby body structures—the odds of survival are high. “Prostate cancer is the only cancer that has a five-year survival rate of 96 to 100% when found early,” says Vincent M. Bivins, M.D., FACS, president of Urology Centers of Alabama.

      The American Cancer Society recommends that men at average risk for prostate cancer discuss screening with their healthcare provider at age 50. Men at high risk (which includes Black men in general and any man with a first-degree relative who had prostate cancer) should have the conversation at age 45. Black men with a family history of breast, ovarian, or prostate cancer should discuss getting screened at age 40.

      Unfortunately, research shows that Black men are less likely to receive prostate cancer screening than white men. While factors like social barriers, distrust of the healthcare system and stigma surrounding prostate cancer play a role, a general lack of awareness and understanding of the disease is also a huge issue, says Dr. Bivins.

      That’s why, as part of its Our Race to Health Equity initiative that aims to eliminate racial health disparities, Johnson & Johnson has launched Talk That TalkTM. This educational campaign and movement focuses on inspiring Black men to take action, normalizing prostate health discussions and encouraging early detection. Through the campaign’s website, monologue videos, social media channels and consumer-friendly resources—such as a screening checklist, guide to talking to your doctor and PSA tracker tool—Talk That Talk is designed to empower Black men to make prostate health and regular screening a priority.

      For Black History Month, we spoke with Dr. Bivins to learn more about the importance of early detection, the reasons for prostate cancer disparities and why removing stigma is vital to saving lives.

      Q:

      What’s driving the racial disparities surrounding prostate cancer diagnoses and survival rates?

      A:

      Studies suggest there’s probably a genetic factor that results in Black men having higher diagnosis rates than men of other backgrounds. We’re still trying to understand this.

      A designed statistic about prostate cancer cases in Black men

      But the fact that Black men are also more likely to be diagnosed with more advanced stage prostate cancer is probably due to a delay in screening. The possible reasons for this delay are multifactorial. You’re looking at education: Are they aware of the screening guidelines? You’re looking at access: Do people have good access to doctors in these communities? Are screening processes set up so we can catch the cancer at an early stage?

      The social determinants of health—such as a person’s financial stability and access to quality medical care—also play an important part. Early on, prostate cancer has no symptoms. So if I only have $100, do I spend $50 to go across town to a doctor if I’m not having any symptoms? For some people, it’s probably not going to happen.

      Q:

      How aware are your patients of the facts surrounding prostate cancer and race?

      A:

      I have a suburban, an urban and a rural population in three different offices. I think each one has a different level of how connected they are with their health. Some are more educated about their health and more educated about prostate cancer. I have some people who know the data just as well as I do, if not better.

      But I also get men who come in and don’t know my name. They just know they have an appointment. They don’t know what medication they’re taking; they just know they take a white or blue pill.

      When I try to educate them about prostate cancer, they say, “Whoa, Doc! I feel okay. I feel normal.” Then I have to explain that prostate cancer may not cause any signs or symptoms in the early stages.

       A close-up of a gloved hand holding a lab vial

      Trying to get them to do a prostate-specific antigen (PSA) blood test (a widely used screening test that can detect prostate cancer) is usually easy. But getting them to agree to a digital rectal exam (which can confirm if the prostate is enlarged—a possible sign of cancer) is very challenging, especially if they have no symptoms.

      Q:

      Do you think prostate cancer has a taboo preventing people from talking about it?

      A:

      Absolutely. As Black men, we keep things close to the hip. I’ve diagnosed patients with prostate cancer, and they say they’re not going to tell their wife or kids. One guy has been cured of prostate cancer for seven years, and he never told his wife. It’s just that stigma.

      Also, with the history of mistreatment of African Americans in general and within the medical world, such as the Tuskegee experiment, there’s distrust in the healthcare system.

      Some men don’t want to get a PSA because they might be diagnosed with cancer—and they think back to the experiences of their fathers or uncles with prostate cancer, when treatment was more likely to lead to complications like incontinence and impotence. That sort of became the brand, even though the technology has greatly improved, and complications are not as bad compared to 30 years ago.

      As we educate men, we explain that technology has greatly improved and treatment options have fewer risks, while highlighting that men diagnosed with prostate cancer are living a normal lifestyle. With this information, the conversation will change.

      Q:

      What about reducing the stigma associated with the digital rectal exam, which is part of screening?

      A:

      We’ve got to take that “invading” stigma away. First, we have to help men understand the importance of the exam. That means explaining that 18% of people with prostate cancer have a normal PSA, and the only way you’re going to find cancer in those patients is through a digital rectal exam. It’s also incumbent upon the provider to help men relax and not rush through the exam.

      Q:

      What’s the best way to educate men and help end the disparities in prostate cancer rates?

      A:

      We need to focus on education. Let’s get into the barbershops, churches, social clubs, fraternities and community organizations. Get men involved, and let’s make them deputies of prostate cancer care.

      We must educate people to understand that preventive measures are important because they allow us to detect and address possible problems early on.

      Let’s empower healthcare providers to get screenings going. Let’s put money toward screenings and prevention. Let’s meet Black men where they are and get them screened and treated appropriately. Fortunately, prostate cancer is one disease that, with early detection, you really can impact and potentially save lives.

      Helping tackle racial disparities in prostate cancer

      The Blue Jacket Fashion Show—which is sponsored by Johnson & Johnson and benefits advocacy group ZERO Prostate Cancer—is raising awareness of the disease in Black and Latine men.

      More from Johnson & Johnson

      Health & wellness
      3D human heart anatomy illustrations

      Do you know what heart failure is? (Hint: It’s probably not what you think)

      For American Heart Month, learn about the advances Johnson & Johnson is making to help turn heart failure into heart recovery for the millions of adults in the U.S. living with the condition, which occurs when the heart muscle isn’t able to pump blood as well as it should.
      Innovation
      Two cardiac electrophysiologists performing a cardiac ablation procedure to treat AFib

      What is cardiac ablation?

      For American Heart Month, learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
      Latest news
       Biomedical scientist Robert Langer headshot

      Biomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research

      Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.